The U.S. Food and Drug Administration has approved an over-the-counter naloxone nasal spray. Called Narcan, the medicine that can reverse an opioid-related overdose can now be purchased in drug, convenience and grocery stores, as well as at gas stations and online.

This article explores the impact the COVID-19 pandemic has had on mental health and substance use, from before and after the pandemic.

Register to attend this webinar, April 26, 2023 at 12 noon CT, to learn more about the three substances use disorders that can be treated with FDA-approved MAT. This is the third of the eight-part webinar series, Current and Emerging Health Issues Related to Opioid Use and Substance Use, and also addresses the post-acute withdrawal syndrome and its potential duration.

Register to attend this webinar, May 17, 2023 at 12 noon CT, to learn more about the American Society of Addiction Medicine's outpatient addiction treatment levels. This is the fourth of the eight-part webinar series, Current and Emerging Health Issues Related to Opioid Use and Substance Use, and also addresses how to address opioid use disorder in a general medical setting.

This new index is designed to assess the “recovery environment” in each U.S. county. The tool provides information on the availability of different treatment options, support systems for people in recovery, and social factors such as housing costs, transportation, and more.

This motivational postcard from the CDC provides awareness that there is a way out of addiction, there is hope, and recovery is possible.

This Opioid Patient Prescriber Agreement from the Food and Drug Administration (FDA) can be shared with patients to help them make informed decisions about opioid treatment for acute or persistent pain and encourage safe and appropriate use.

This infogram from National Institute for Health Care Management (NIHCM) provides a high-level overview of the community-level strategies to reduce drug overdose deaths include promoting evidence-based solutions in prevention, harm reduction, treatment and recovery efforts.

Medicine take back options are the best way to safely dispose of unused or expired prescription and nonprescription (for example, over the counter) medicines. Use this U.S. Food & Drug Administration (FDA) site to find drug take back locations.

The Screener and Opioid Assessment for Patients with Pain- Revised (SOAPP®-R) is a tool for clinicians to help determine how much monitoring a patient on long-term opioid therapy might require.

Through its Shine a Light on Stigma campaign, Superior Health--a Quality Innovation Network – Quality Improvement Organization--is encouraging individuals and organizations to pledge their commitment to using non-stigmatizing, person-centered language when interacting with people with substance use disorder.

This resource offers general recommendations for treating chronic pain. Included are guidelines and tools for determining when to prescribe opioids. From the Michigan Department of Health and Human Services and the University of Michigan's Injury Prevention Center.

Fulfill state-mandated requirements while learning best practices for managing patients' pain through the free New England Journal of Medicine (NEJM) Knowledge+ Pain Management and Opioids CME module. The module is offered in partnership with Boston University School of Medicine's Safer/Competent Opioid Prescribing Education (SCOPE of Pain) program.

Download this two-page handout the TMF Quality Innovation Network developed to ensure providers offer effective pain management and care of patients with opioid use disorder (OUD).

This document has links to the Prescription Drug Montoring Programs in Arkansas, Mississippi, Nebraska, the U.S. territory of Puerto Rico and Texas.

The National Naloxone Map, maintained by New America, to see where naloxone is available in your state. (If the interactive map doesn’t appear when you click on the link, try copying and opening the link in a different browser.)

Pain continues to be the one of the most common reasons many patients seek medical care in the United States, writes the American Medical Association (AMA), The AMA Pain Care Task Force, formed in 2018, explores safe and effective ways to care for patients with undertreated, mistreated pain and chronic pain. This document explains the AMA's principles of pain care.

Opioid use disorder (OUD) is a chronic, relapsing condition, according to the AAFP. This AAFP practice manual proposes that OUD treatment is within the family physician’s scope of practice and guides primary care providers in incorporating opioid screening and brief interventions, as well as evidence-based treatment.

Operation Naloxone, funded by a SAMHSA grant program, is intended, in part, to prepare, locate and implement trainings across Texas in opioid awareness, overdose prevention and naloxone use. Naloxone counters the effects of opioid overdoses by allowing overdose victims to resume normal breathing.

Hospitals and other health care facilities can download this tool from TMF Health Quality Institute to help them assess their readiness to prevent or react to an adverse drug event.

A brief, self-report screening tool designed for use with adult patients in primary care settings to assess risk for opioid abuse among those prescribed opioids for treatment of chronic pain.

The Substance Abuse and Mental Health Services Administration (SAMHSA) maintains this directory, which lists programs available in the United States. Access your state from the drop-down menu.

This Centers for Disease Control and Prevention fact sheet provides clinical guidance on dosage of opioids for treatment of chronic pain.

Download this tool from the Center to Advance Palliative Care. Some sections of the form should be filled out by the practice’s clinician; other sections should be filled out by the physician.

Medication reconciliation is a complex process that impacts all patients as they move through various health care settings. This toolkit item provides tips for conducting a patient medication interview.

This TMF Quality Innovation Network change package provides a menu of options from which you can select specific interventions to develop an action plan that improves opioid-related outcomes and increases access to behavioral health services.

Use this U.S. map to locate physicians authorized to treat opioid dependency with buprenorphine. Language assistance available for Spanish and multiple languages.

Give this resource to patients with high pain levels to help them learn when to call the doctor or visit an emergency room.

TMF Quality Innovation Network, en virtud del contrato con CMS, preparó este paquete para facilitar el cambio y proporcionar a las comunidades estrategias para combatir el abuso, el uso inapropiado y las sobredosis de opioides y aumentar el acceso a los servicios de salud del comportamiento.